Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $2.30 $3.38 Friday, 10th May 2024 CLLS stock ended at $3.06. This is 5.56% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 9.00% from a day low at $3.00 to a day high of $3.27.
90 days $2.30 $3.38
52 weeks $0.96 $3.77

Historical Cellectis S.A. prices

Date Open High Low Close Volume
Nov 28, 2016 $17.40 $17.98 $17.27 $17.40 92 043
Nov 25, 2016 $18.05 $18.08 $17.49 $18.05 92 198
Nov 23, 2016 $17.41 $17.67 $16.83 $17.41 221 087
Nov 22, 2016 $17.94 $18.11 $17.70 $17.94 90 562
Nov 21, 2016 $18.00 $18.06 $17.65 $18.00 81 474
Nov 18, 2016 $18.35 $18.53 $17.63 $17.92 99 511
Nov 17, 2016 $18.31 $19.48 $18.27 $18.31 164 383
Nov 16, 2016 $20.28 $20.67 $19.63 $19.70 268 145
Nov 15, 2016 $19.16 $19.18 $18.68 $18.74 59 779
Nov 14, 2016 $19.17 $19.20 $18.70 $19.09 76 409
Nov 11, 2016 $19.04 $19.50 $18.83 $19.13 79 920
Nov 10, 2016 $19.20 $19.84 $18.96 $19.32 129 208
Nov 09, 2016 $17.75 $18.17 $17.03 $18.15 195 662
Nov 08, 2016 $16.71 $16.76 $16.40 $16.56 92 782
Nov 07, 2016 $17.12 $17.12 $16.35 $16.69 106 900
Nov 04, 2016 $17.08 $17.26 $16.95 $17.19 93 300
Nov 03, 2016 $17.67 $17.83 $17.09 $17.09 73 200
Nov 02, 2016 $18.03 $18.05 $17.21 $17.32 55 000
Nov 01, 2016 $17.54 $17.89 $17.50 $17.80 50 000
Oct 31, 2016 $17.75 $17.94 $17.58 $17.68 51 900
Oct 28, 2016 $18.23 $18.32 $17.94 $17.95 58 300
Oct 27, 2016 $18.49 $18.80 $18.08 $18.11 143 200
Oct 26, 2016 $18.00 $18.49 $17.94 $18.01 105 800
Oct 25, 2016 $18.35 $18.44 $18.00 $18.06 101 000
Oct 24, 2016 $19.10 $19.10 $18.50 $18.52 64 800
Click to get the best stock tips daily for free!

About Cellectis S.A.

Cellectis S.A. Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatment of CD19-expressing hematologic malignancies, such as acute lymphoblastic leukemia; ALLO-501 and ALL... CLLS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT